The market resolves to Yes if the EMA announces PRIME designation for an ALS treatment on or before July 24, 2026. Otherwise No.
Resolves Yes if The market resolves to Yes if the EMA announces PRIME designation for an ALS treatment on or before July 24, 2026. Otherwise No.
Outcome verified from ema.europa.eu.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…